Protective effect of tanshinone IIA against infarct size and increased HMGB1, NFκB, GFAP and apoptosis consequent to transient middle cerebral artery occlusion

Neurochemical Research

Volumn 39, Issue 2, 2014, Pages 295-304

  Wang, Jian Gang ^a   Bondy, Stephen C ^b   Zhou, Li ^a   Yang, Feng Zhen ^c   Ding, Zhi Gang ^a   Hu, Yu ^a   Tian, Yun ^a   Wen, Pu Yuan ^a   Luo, Hao ^c   Wang, Fang ^c   Li, Wen Wen ^c   Zhou, Jun ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Central South University   (China)

Author keywords

Apoptosis; Inflammation; Middle cerebral artery occlusion; Tanshinone IIA

Indexed keywords

GLIAL FIBRILLARY ACIDIC PROTEIN; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TANSHINONE IIA;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPLASM; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CEREBRAL INFARCTION; DITERPENES, ABIETANE; GLIAL FIBRILLARY ACIDIC PROTEIN; HMGB1 PROTEIN; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROPROTECTIVE AGENTS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84893272630     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-013-1221-y     Document Type: Article

References (45)

1. Andersson U, Wang H, Palmblad K, Aveberger AC, Bloom O, Erlandsson-Harris H, Janson A, Kokkola R, Zhang M, Yang H, Tracey KJ (2000) High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 192:565-570
2. Cho BB, Toledo-Pereyra LH (2008) Caspase-independent programmed cell death following ischemic stroke. J Invest Surg 21:141-147
3. Choi JH, Yoo KY, Lee CH, Park O, Yan BC, Li H, Moon YS, Hwang IK, Lee YL, Shin HC, Won MH (2010) Transient cerebral ischemia induces active astrocytosis without distinct neuronal death in the gerbil main olfactory bulb: a long-term analysis. Neurochem Res 35:1588-1598
4. Clemens JA, Stephenson DT, Dixon EP, Smalstig EB, Mincy RE, Rash KS, Little SP (2008) Global cerebral ischemia activates nuclear factor-kappa B prior to evidence of DNA fragmentation. Brain Res Mol Brain Res 48:187-196
5. Dong K, Xu W, Yang J, Qiao H, Wu L (2009) Neuroprotective effects of tanshinone IIA on permanent focal cerebral ischemia in mice. Phytother Res 23:608-613
6. Durukan A, Tatlisumak T (2007) Acute ischemic stroke: overview of major experimental rodent models, pathophysiology, and therapy of focal cerebral ischemia. Pharmacol Biochem Behav 87:179-197
7. Feigin VL, Lawes CM, Bennett DA, Anderson CS (2003) Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2:43-53
8. Froehler MT, Ovbiagele B (2010) Therapeutic hypothermia for acute ischemic stroke. Expert Rev Cardiovasc Ther 8:593-603
9. Gao J, Yang G, Pi R, Li R, Wang P, Zhang H, Le K, Chen S, Liu P (2008) Tanshinone IIA protects neonatal rat cardiomyocytes from adriamycin-induced apoptosis. Transl Res 151:79-87
10. Goldstein RS, Gallowitsch-Puerta M, Yang L, Rosas-Ballina M, Huston JM, Czura CJ, Lee DC, Ward MF, Bruchfeld AN, Wang H, Lesser ML, Church AL, Litroff AH, Sama AE, Tracey KJ (2006) Elevated high-mobility group box 1 levels in patients with cerebral and myocardial ischemia. Shock 25:571-574
11. Lam BY, Lo AC, Sun X, Luo HW, Chung SK, Sucher NJ (2003) Neuroprotective effects of tanshinones in transient focal cerebral ischemia in mice. Phytomedicine 10:286-291
12. Lee SW, Clemenson GD, Gage FH (2012) New neurons in an aged brain. Behav Brain Res 227:497-507
13. Liu L, Zhang X, Wang L, Yang R, Cui L, Li M, Du W, Wang S (2010) The neuroprotective effects of tanshinone IIA are associated with induced nuclear translocation of TORC1 and upregulated expression of TORC1, pCREB and BDNF in the acute stage of ischemic stroke. Brain Res Bull 82:228-233
14. Longa EZ, Weinstein PR, Carlson S, Cummins R (1989) Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20:84-91
15. Luan ZG, Zhang H, Yang PT, Ma XC, Zhang C, Guo RX (2010) HMGB1 activates nuclear factor-κB signaling by RAGE and increases the production of TNF-alpha in human umbilical vein endothelial cells. Immunobiology 215:956-962
16. Muhammad S, Barakat W, Stoyanov S, Murikinati S, Yang H, Tracey KJ, Bendszus M, Rossetti G, Nawroth PP, Bierhaus A, Schwaninger M (2008) The HMGB1 receptor RAGE mediates ischemic brain damage. J Neurosci 28:12023-12031
17. Niu XL, Ichimori K, Yang X, Hirota Y, Hoshiai K, Li M, Nakazawa H (2000) Tanshinone II-A inhibits low density lipoprotein oxidation in vitro. Free Rad Res 33:305-312
18. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, Ballantyne CM, Gahmberg CG, Bianchi ME, Nawroth PP, Chavakis T (2007) A novel pathway of HMGB1 mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J 26:1129-1139
19. Palumbo R, Galvez BG, Pusterla T, De Marchis F, Cossu G, Marcu KB, Bianchi ME (2007) Cells migrating to sites of tissue damage in response to the danger signal HMGB1 require NF-κB activation. J Cell Biol 179:33-40
20. Park JS, Gamboni-Robertson F, He Q, Svetkauskaite D, Kim JY, Strassheim D, Sohn JW, Yamada S, Maruyama I, Banerjee A, Ishizaka A, Abraham E (2006) High mobility group box 1 protein interacts with multiple toll-like receptors. Am J Physiol Cell Physiol 290:C917-C924
21. Pendlebury ST, Rothwell PM (2009) Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis. Lancet Neurol 8:1006-1018
22. Pluta R, Kocki J, Maciejewski R, Ułamek-Kozioł M, Jabłoński M, Bogucka-Kocka A, Czuczwar SJ (2012) Ischemia signalling to Alzheimer-related genes. Folia Neuropathol 50:322-329
23. Pluta R, Jabłoński M, Ułamek-Kozioł M, Kocki J, Brzozowska J, Januszewski S, Furmaga-Jabłońska W, Bogucka-Kocka A, Maciejewski R, Czuczwar SJ (2013) Sporadic Alzheimer's disease begins as episodes of brain ischemia and ischemically dysregulated Alzheimer's disease genes. Mol Neurobiol 48:500-515
24. Qian YH, Xiao Q, Xu J (2012) The protective effects of tanshinone IIA on β-amyloid protein (1-42)-induced cytotoxicity via activation of the Bcl-xL pathway in neuron. Brain Res Bull 88:354-358
25. Qiu J, Nishimura M, Wang Y, Sims JR, Qiu S, Savitz SI, Salomone S, Moskowitz MA (2008) Early release of HMGB-1 from neurons after the onset of brain ischemia. J Cereb Blood Flow Metab 28:927-938
26. Ridder DA, Schwaninger M (2009) NF-κB signaling in cerebral ischemia. Neuroscience 158:995-1006
27. Scaffidi P, Misteli T, Bianchi ME (2002) Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418:191-195
28. Sekeljic V, Bataveljic D, Stamenkovic S, Ułamek M, Jabłoński M, Radenovic L, Pluta R, Andjus PR (2012) Cellular markers of neuroinflammation and neurogenesis after ischemic brain injury in the long-term survival rat model. Brain Struct Funct 217:411-420
29. Tang C, Xue H, Bai C, Fu R, Wu A (2010) The effects of tanshinone IIA on blood-brain barrier and brain edema after transient middle cerebral artery occlusion in rats. Phytomedicine 17:1145-1149
30. Thomas JO, Travers AA (2001) HMG1 and 2, and related 'architectural' DNA-binding proteins. Trends Biochem Sci 26:167-174
31. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, Parroche P, Drabic S, Golenbock D, Sirois C, Hua J, An LL, Audoly L, La Rosa G, Bierhaus A, Naworth P, Marshak-Rothstein A, Crow MK, Fitzgerald KA, Latz E, Kiener PA, Coyle AJ (2007) Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nature Immunol 8:487-496
32. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, Andersson U, Yang H, Tracey KJ, Andersson J, Palmblad JE (2003) High mobility group 1 B-box mediates activation of human endothelium. J Intern Med 254:375-385
33. Tsung A, Zheng N, Jeyabalan G, Izuishi K, Klune JR, Geller DA, Lotze MT, Lu L, Billiar TR (2007) Increasing numbers of hepatic dendritic cells promote HMGB1-mediated ischemia-reperfusion injury. J Leukoc Biol 81:119-128
34. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ (1999) HMG-1 as a late mediator of endotoxin lethality in mice. Science 285:248-251
35. Wang Q, Yu X, Patal K, Hu R, Chuang S, Zhang G, Zheng J (2013) Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells. ACS Chem Neurosci 4:1004-1015
36. Wang L, Zhang X, Liu L, Cui L, Yang R, Li M, Du W (2010) Tanshinone II A down-regulates HMGB1, RAGE, TLR4, NF-κB expression, ameliorates BBB permeability and endothelial cell function, and protects rat brains against focal ischemia. Brain Res 1321:143-151
37. Wexler EJ, Peters EE, Gonzales A, Gonzales ML, Slee AM, Kerr JS (2002) An objective procedure for ischemic area evaluation of the stroke intraluminal thread model in the mouse and rat. J Neurosci Methods 113:51-58
38. Xia WJ, Yang M, Fok TF, Li K, Chan WY, Ng PC, Ng HK, Chik KW, Wang CC, Gu GJ, Woo KS, Fung KP (2005) Partial neuroprotective effect of pretreatment with tanshinone IIA on neonatal hypoxia-ischemia brain damage. Pediatr Res 58:784-790
39. Xie XY, Zhang B, Li JH, Fan QX, Zhang Y, Mu DG, Li WP, Xu M, Zhao PT, Jin FG, Li ZC (2011) Sodium tanshinone IIA sulfonate attenuates seawater aspiration-induced acute pulmonary edema by up-regulating Na(+), K(+)-ATPase activity. Exp Lung Res 37:482-491
40. Xu W, Yang J, Wu LM (2009) Cardioprotective effects of tanshinone IIA on myocardial ischemia injury in rats. Pharmazie 64:332-336
41. Yang D, Chen Q, Yang H, Tracey KJ, Bustin M, Oppenheim JJ (2007) High mobility group box-1 protein induces the migration and activation of human dendritic cells and acts as an alarmin. J Leukoc Biol 81:59-66
42. Yu XY, Lin SG, Zhou ZW, Chen X, Liang J, Liu PQ, Duan W, Chowbay B, Wen JY, Li CG, Zhou SF (2007) Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge. Curr Drug Metab 8:325-340
43. Zhang W, Potrovita I, Tarabin V, Herrmann O, Beer V, Weih F, Schneider A, Schwaninger M (2005) Neuronal activation of NF-κB contributes to cell death in cerebral ischemia. J Cereb Blood Flow Metab 25:30-40
44. Zhou J, Fonseca MI, Pisalyaput K, Tenner AJ (2008) Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease. J Neurochem 106:2080-2092
45. Zhou J, Zhou L, Hou D, Tang J, Sun J, Bondy SC (2011) Paeonol increases levels of cortical cytochrome oxidase and vascular actin and improves behavior in a rat model of Alzheimer's disease. Brain Res 1388:141-147